Leap Investments’s Novavax NVAX Stock Holding History

Leap Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$242K	Sell	2,900 -7,100	-71%	-$272K	0.16%	254
2020 Q1	$136K	Sell	10,000 -24,429	-71%	-$207K	0.2%	210
2019 Q4	$137K	Buy	+34,429	New	+$149K	0.06%	358

Other funds holding NVAX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Leap Investments's NVAX Position: Q2 2020 in Review

Leap Investments reduced its Novavax (NVAX) stake by 71% in Q2 2020, selling an estimated $272K and leaving 2,900 shares worth $242K. The position accounts for 0.16% of the portfolio, ranked #254.

Leap Investments first reported a position in NVAX in Q4 2019 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold NVAX as of Q2 2020.

Leap Investments held 2,900 shares of Novavax worth $242K as of Q2 2020.
Leap Investments sold 7,100 Novavax shares in Q2 2020, an estimated $272K.
Novavax made up 0.16% of Leap Investments's portfolio in Q2 2020, its #254 holding.
Leap Investments first reported a position in Novavax in Q4 2019 and has held it in 3 quarters since.
213 funds tracked by Wall St. Rank held Novavax as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.